FDA Inspection 807056 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on Nov 15, 2012 in Rye, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 15, 2012
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rye, NY (United States)